This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Day One Biopharmaceuticals, Inc., Dot Therapeutics-1, Inc.. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: Motoki Ikeuchi: Innovator in Optically Active Compounds
Introduction
Motoki Ikeuchi is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of chemistry, particularly in the production of optically active compounds. With a total of 2 patents to his name, Ikeuchi's work is recognized for its industrial applicability and innovative methodologies.
Latest Patents
Ikeuchi's latest patents focus on a method for producing optically active pyrimidinamide derivatives on an industrial scale. The process involves subjecting a compound (I) or a salt thereof to an asymmetric reduction reaction. The resulting compound (II) or its salt undergoes a deprotection reaction, leading to compound (III) or its salt. This compound is then reacted with compound (VI) or its salt to yield compound (V) or its salt, as detailed in the specifications of his patents.
Career Highlights
Throughout his career, Motoki Ikeuchi has worked with notable companies such as Dot Therapeutics, Inc. and Day One Biopharmaceuticals, Inc. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical chemistry.
Collaborations
Ikeuchi has collaborated with esteemed colleagues, including Sayuri Hirano and Yoshiyuki Takeda. These partnerships have fostered a collaborative environment that enhances the development of new technologies and methodologies in his field.
Conclusion
Motoki Ikeuchi's contributions to the field of optically active compounds demonstrate his commitment to innovation and industrial application. His patents reflect a deep understanding of chemical processes and a drive to advance the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile